Skip to content

Long-Term Experience and Health Effects of COVID-19

A Longitudinal, Long-Term, Observational Study of COVID-19 Experience and Health Effects

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04477902
Enrollment
64
Registered
2020-07-20
Start date
2020-07-01
Completion date
2021-06-22
Last updated
2021-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona Virus Infection, Covid19, Quality of Life, Risk Reduction

Keywords

covid-19, corona virus, covid19, coronavirus, SARS-CoV-2, infection, household, transmission, vaccine, clinical trials, online, Altura, outpatient, telemedicine

Brief summary

The purpose of this study is to gain on-going COVID-19 feedback/data to drive timely action locally and nationally in order to mitigate transmission. Data will be deidentified and consolidated to create a large national longitudinal database.

Detailed description

Ths is a longitudinal, observational, descriptive study to gather data needed to support a better understanding of COVID-19 from the perspective of a diverse national population. This multi-phase study will use an action research approach to identify specific ways that physician groups, federally qualified health centers (FQHCs), public health departments, and other health and social services systems in the United States can address healthcare needs and mitigate the transmission of COVID-19. Email surveys will be used to assess the historical and current status of participants by medical condition, geography, and demographic characteristics, as well as their history of symptoms (e.g. recent cough, fever, loss of sense of taste or smell, etc.) and their current psychosocial needs. The study will provide the structure for an iterative exploration of trends over time (up to 24 months). The opt-in survey will be posted and available to individuals 18 and older who choose to participate. Survey frequency will be every two weeks. To analyze broader trends, all survey responses will be de-identified and aggregated. Overall general findings will not be linked to individuals or physician groups when reporting and publishing study results.

Interventions

online survey

Sponsors

Altura
Lead SponsorINDUSTRY

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older * Any gender specification * Has consented to proceed with survey * Is able to complete the survey via email on a regular basis

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Longitudinal survey2 yearsTo gain on-going COVID-19 feedback/data to drive timely action locally and nationally in order to mitigate transmission.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026